Comparative research for the healthcare budget and burden of disease in perspective resource allocation

So Youn Park, Seok-Jun Yoon, Hyesook Park, Min Woo Jo, In Hwan Oh

Research output: Contribution to journalArticle

Abstract

Background: Burden of disease can be used to prioritize the healthcare budget allocation. We analyzed the research and development (R&D) budget of the Ministry of Health and Welfare (MOHW) in 2018 and compared the results with those of the 2015 Korean National Burden of Disease (KNBD) study. Methods: The 2018 MOHW R&D Project integrated implementation plan was used to analyze the R&D budget of the MOHW. The budget was allocated according to the KNBD disease group and according to the budget lines. The allocated budget was compared with the economic burden and the disability adjusted life years (DALYs) in 2015. Also, for budget targets for risk factors, DALYs of attributable risk factors were compared with corresponding budgets. Results: In 2018, the MOHW major R&D budget of USD 435.1 million accounted for 3% of the total government budget. Within the disease specific R&D budget, 35.9% was allocated to communicable disease groups, 64.1% to non-communicable diseases, and 0% to injury and violence. Among level 2 disease groups, neoplasm was ranked first. Among risk factors, climate change and behavioral risk were targeted for R&D. Conclusions: It would be difficult to say that current R&D allocations focus to minimize the burden of disease. A mismatch was observed between the R&D budget and the burden of disease in terms of economic burden and DALYs. There was a similar finding for risk factors R&D. A novel approach for allocating government R&D funding that is based on the goal of minimizing the disease burden in the Korean population should be considered.

Original languageEnglish
Article numbere81
JournalJournal of Korean medical science
Volume34
DOIs
Publication statusPublished - 2019 Mar 26

Fingerprint

Resource Allocation
Health Services Research
Budgets
Quality-Adjusted Life Years
Health
Economics
Climate Change
Violence
Communicable Diseases

Keywords

  • Burden of Disease
  • Korea
  • R&D Funding

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Comparative research for the healthcare budget and burden of disease in perspective resource allocation. / Park, So Youn; Yoon, Seok-Jun; Park, Hyesook; Jo, Min Woo; Oh, In Hwan.

In: Journal of Korean medical science, Vol. 34, e81, 26.03.2019.

Research output: Contribution to journalArticle

@article{a6b7b793622c43c1bfdf602a53f7b44d,
title = "Comparative research for the healthcare budget and burden of disease in perspective resource allocation",
abstract = "Background: Burden of disease can be used to prioritize the healthcare budget allocation. We analyzed the research and development (R&D) budget of the Ministry of Health and Welfare (MOHW) in 2018 and compared the results with those of the 2015 Korean National Burden of Disease (KNBD) study. Methods: The 2018 MOHW R&D Project integrated implementation plan was used to analyze the R&D budget of the MOHW. The budget was allocated according to the KNBD disease group and according to the budget lines. The allocated budget was compared with the economic burden and the disability adjusted life years (DALYs) in 2015. Also, for budget targets for risk factors, DALYs of attributable risk factors were compared with corresponding budgets. Results: In 2018, the MOHW major R&D budget of USD 435.1 million accounted for 3{\%} of the total government budget. Within the disease specific R&D budget, 35.9{\%} was allocated to communicable disease groups, 64.1{\%} to non-communicable diseases, and 0{\%} to injury and violence. Among level 2 disease groups, neoplasm was ranked first. Among risk factors, climate change and behavioral risk were targeted for R&D. Conclusions: It would be difficult to say that current R&D allocations focus to minimize the burden of disease. A mismatch was observed between the R&D budget and the burden of disease in terms of economic burden and DALYs. There was a similar finding for risk factors R&D. A novel approach for allocating government R&D funding that is based on the goal of minimizing the disease burden in the Korean population should be considered.",
keywords = "Burden of Disease, Korea, R&D Funding",
author = "Park, {So Youn} and Seok-Jun Yoon and Hyesook Park and Jo, {Min Woo} and Oh, {In Hwan}",
year = "2019",
month = "3",
day = "26",
doi = "10.3346/jkms.2019.34.e81",
language = "English",
volume = "34",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",

}

TY - JOUR

T1 - Comparative research for the healthcare budget and burden of disease in perspective resource allocation

AU - Park, So Youn

AU - Yoon, Seok-Jun

AU - Park, Hyesook

AU - Jo, Min Woo

AU - Oh, In Hwan

PY - 2019/3/26

Y1 - 2019/3/26

N2 - Background: Burden of disease can be used to prioritize the healthcare budget allocation. We analyzed the research and development (R&D) budget of the Ministry of Health and Welfare (MOHW) in 2018 and compared the results with those of the 2015 Korean National Burden of Disease (KNBD) study. Methods: The 2018 MOHW R&D Project integrated implementation plan was used to analyze the R&D budget of the MOHW. The budget was allocated according to the KNBD disease group and according to the budget lines. The allocated budget was compared with the economic burden and the disability adjusted life years (DALYs) in 2015. Also, for budget targets for risk factors, DALYs of attributable risk factors were compared with corresponding budgets. Results: In 2018, the MOHW major R&D budget of USD 435.1 million accounted for 3% of the total government budget. Within the disease specific R&D budget, 35.9% was allocated to communicable disease groups, 64.1% to non-communicable diseases, and 0% to injury and violence. Among level 2 disease groups, neoplasm was ranked first. Among risk factors, climate change and behavioral risk were targeted for R&D. Conclusions: It would be difficult to say that current R&D allocations focus to minimize the burden of disease. A mismatch was observed between the R&D budget and the burden of disease in terms of economic burden and DALYs. There was a similar finding for risk factors R&D. A novel approach for allocating government R&D funding that is based on the goal of minimizing the disease burden in the Korean population should be considered.

AB - Background: Burden of disease can be used to prioritize the healthcare budget allocation. We analyzed the research and development (R&D) budget of the Ministry of Health and Welfare (MOHW) in 2018 and compared the results with those of the 2015 Korean National Burden of Disease (KNBD) study. Methods: The 2018 MOHW R&D Project integrated implementation plan was used to analyze the R&D budget of the MOHW. The budget was allocated according to the KNBD disease group and according to the budget lines. The allocated budget was compared with the economic burden and the disability adjusted life years (DALYs) in 2015. Also, for budget targets for risk factors, DALYs of attributable risk factors were compared with corresponding budgets. Results: In 2018, the MOHW major R&D budget of USD 435.1 million accounted for 3% of the total government budget. Within the disease specific R&D budget, 35.9% was allocated to communicable disease groups, 64.1% to non-communicable diseases, and 0% to injury and violence. Among level 2 disease groups, neoplasm was ranked first. Among risk factors, climate change and behavioral risk were targeted for R&D. Conclusions: It would be difficult to say that current R&D allocations focus to minimize the burden of disease. A mismatch was observed between the R&D budget and the burden of disease in terms of economic burden and DALYs. There was a similar finding for risk factors R&D. A novel approach for allocating government R&D funding that is based on the goal of minimizing the disease burden in the Korean population should be considered.

KW - Burden of Disease

KW - Korea

KW - R&D Funding

UR - http://www.scopus.com/inward/record.url?scp=85063511158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063511158&partnerID=8YFLogxK

U2 - 10.3346/jkms.2019.34.e81

DO - 10.3346/jkms.2019.34.e81

M3 - Article

VL - 34

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

M1 - e81

ER -